Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
chronic disease
Research
ARPA-H launches $158M effort for first lymphatic meds
No medicines or devices specifically targeting the lymphatic system have been approved by the FDA.
Darren Incorvaia
Mar 4, 2026 8:55am
Chugai drops only AI-assisted antibody from pipeline
Jan 30, 2026 10:55am
Convatec report finds social stigma tied to chronic conditions
Oct 28, 2025 8:15am
AstraZeneca pens $5.3B pact with CSPC to develop oral drugs
Jun 13, 2025 5:56am
Amgen disappears lung disease program after phase 2 fail
Oct 30, 2024 5:59pm
Qiagen, AstraZeneca expand DNA test collaboration beyond cancer
Aug 29, 2024 11:30am
